Aridis Pharmaceuticals has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Aridis Pharmaceuticals has averaged an EPS surprise of 2.41% and a revenue surprise of 0.76%.
Analyze the earnings history of Aridis Pharmaceuticals using advanced sorting and filters.
The chart below shows Aridis Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Aridis Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
Aridis Pharmaceuticals (ARDS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 3, 2023 for Q3.
Aridis Pharmaceuticals (ARDS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 3, 2023 for Q3 and the Actual EPS was $0.00, which hit the estimate of $0.00.
Aridis Pharmaceuticals (ARDS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 3, 2023 for Q3 and the Actual Revenue was $417.00K, which beat the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2022-11-21 | $-0.47 | $-0.17 | -176.5 % |
| Q2 | 2022-08-16 | $-0.45 | $-0.06 | -650.0 % |
| Q1 | 2022-05-16 | $-0.44 | $-0.51 | 13.7 % |
| Q4 | 2022-03-31 | $-0.92 | $-0.41 | -124.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2022-11-21 | $399.00K | $7.47M | -94.7 % |
| Q2 | 2022-08-16 | $292.00K | $10.46M | -97.2 % |
| Q1 | 2022-05-16 | $1.19M | $2.00M | -40.6 % |
| Q4 | 2022-03-31 | $570.00K | $1.90M | -70.0 % |